Results 21 to 30 of about 5,479,219 (149)

Exercise Capacity, Endothelial Function, Muscle Mass, and Strength in Pediatric Patients With Fontan Circulation

open access: yesCJC Pediatric &Congenital Heart Disease, Volume 5, Issue 3, Page 119-128, June 2026.
Abstract Background Fontan circulation carries high morbidity and mortality, driven in part by impaired exercise capacity, muscle deficits, and endothelial dysfunction. In a pediatric cohort with Fontan circulation, we examined associations between exercise capacity, endothelial function, and muscle parameters before enrollment in a randomized exercise
Mavis C. Lui   +11 more
wiley   +1 more source

Skin autofluorescence in diabetes mellitus [PDF]

open access: yes, 2008
AGEs ofwel advanced glycation endproducts zijn onomkeerbaar versuikerde stoffen, die voornamelijk aan eiwitten zijn gekoppeld, en die bij ieder mens stapelen. Bij iemand met diabetes mellitus gaat dit proces echter versneld.
Lutgers, Helen Lucia   +2 more
core   +14 more sources

Comparison of Labscan 200 and FlexMap 3D Luminex for Anti‐HLA Antibodies Monitoring

open access: yesHLA, Volume 107, Issue 5, May 2026.
ABSTRACT The new Luminex model FlexMap 3D is progressively replacing the previous Luminex generation in HLA laboratories for the detection and identification of anti‐HLA antibodies. FlexMap 3D Luminex promises a higher degree of sensitivity, which may lead to greater mean fluorescence intensities, depending on the anti‐HLA beads kit supplier.
J. Milhès   +6 more
wiley   +1 more source

Prevention and Management of Percutaneous Coronary Intervention‐Related Complications: Assessing the Impact of Simulation‐Based Learning and Human Factors Training

open access: yesCatheterization and Cardiovascular Interventions, Volume 107, Issue 4, Page 960-968, March 1, 2026.
ABSTRACT Background Complications of percutaneous coronary intervention (PCI) remain infrequent but are associated with a risk of serious injury or death. The techniques and devices required to manage them may be unfamiliar or unavailable to operators.
Junichi Fukamizu   +25 more
wiley   +1 more source

An Autologous, Vascularized and Immunocompetent Tissue Engineered Skin to Highlight Inter‐Individual Variability to Better Understand the Human Wound Healing

open access: yesWound Repair and Regeneration, Volume 34, Issue 1, January/February 2026.
ABSTRACT In vitro tissue‐engineered skin models are valuable tools for dermatological research. Yet, they often fail to reproduce the complex interactions among vascular, immune, and cutaneous cells during the wound healing process. In addition, inter‐individual variability response remains poorly understood, limiting our knowledge of the genetic and ...
Emilie Attiogbe   +9 more
wiley   +1 more source

Sex‐Specific Lasting Metabolome Effects of Adverse Gestational Conditions and Prevention by Myo‐Inositol Supplementation During Suckling

open access: yesMolecular Nutrition &Food Research, Volume 69, Issue 23, December 2025.
This graphical abstract illustrates the effects of myo‐inositol supplementation during suckling in reducing long‐term metabolic impacts from mild gestational calorie restriction (GCR). Using a metabolomics approach, 164 metabolites were identified, with greater metabolic alterations in males.
Rocío A. Martín‐Chamorro   +6 more
wiley   +1 more source

Prevalence and Impact of Partial Anomalous Pulmonary Venous Connection in Turner Syndrome

open access: yesCJC Pediatric &Congenital Heart Disease, Volume 4, Issue 6, Page 330-337, December 2025.
Abstract Background Patients with Turner syndrome (TS) have a higher mortality than age‐matched females, mainly due to cardiovascular disorders. Recently, an increased prevalence of partial anomalous pulmonary venous connection (PAPVC) was described in patients with TS.
Estelle Tenisch   +10 more
wiley   +1 more source

Management of patients with heart failure at high risk of hyperkalaemia: The CARE‐HK in HF registry

open access: yesEuropean Journal of Heart Failure, Volume 27, Issue 11, Page 2410-2421, November 2025.
Primary results of the CARE‐HK in HF registry. ACEI, angiotensin‐converting enzyme inhibitor; ARB, angiotensin II receptor blocker; ARNI, angiotensin receptor–neprilysin inhibitor; CI, confidence interval; eGFR, estimated glomerular filtration rate; HF, heart failure; HK, hyperkalaemia; HR, hazard ratio; MRA, mineralocorticoid receptor antagonist; RASi,
Stephen J. Greene   +24 more
wiley   +1 more source

Quelques nouveautés dans les recommandations 2021 pour la prise en charge des dyslipidémies en prévention cardiovasculaire

open access: yes, 2023
En matière de décision thérapeutique pour les dyslipidémies, les nouvelles recommandations européennes 2021 pour la prévention des maladies cardiovasculaires athérosclérotiques (MCVA) apportent quelques nuances par rapport à celles antérieures de 2019 ...
Mertens, Ann   +7 more
core  

Management of von Willebrand Disease With a Factor VIII‐Poor von Willebrand Factor Concentrate: Results From the Paediatric Cohort of a Prospective Observational Post‐Marketing Study

open access: yesHaemophilia, Volume 31, Issue 6, Page 1250-1260, November 2025.
ABSTRACT Introduction Although clinical experience of a triple‐secured, plasma‐derived, von Willebrand factor (pdVWF), almost devoid of Factor VIII (FVIII) in adults with von Willebrand disease (VWD), is widely reported, its use in children is less documented.
Jenny Goudemand   +10 more
wiley   +1 more source

Home - About - Disclaimer - Privacy